Track topics on Twitter Track topics that are important to you
Crescita Therapeutics (TSX:CTX) has announced its financial results for the fourth quarter and year ended December 31, 2018. As quoted in the press release: Financial Highlights Q4-F2018 Revenue of $6.2 million, up $3.8 million or 163.3% versus Q4-F2017; Revenue includes $1.4 million of royalties on the U.S. net sales of Pliaglis and $2.0 million in sales and development milestones; Adjusted EBITDA1 of $1.8 million, … Continued
The post Crescita Therapeutics Reports Fourth Quarter and Fiscal 2018 Results appeared first on Investing News Network.
Original Article: Crescita Therapeutics Reports Fourth Quarter and Fiscal 2018 ResultsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...